Cancer Rates Rise Among Adults Under 50 Across US, UK, and Netherlands
Diagnoses of colorectal cancer and other specific tumors among adults under 50 have risen across the United States, England, and the Netherlands over the last two decades, according to an analysis published by the World Cancer Research Fund (WCRF). The entity tracked research trends between 2000 and 2023 in the US and the Netherlands, and between 2001 and 2023 in England, revealing increased incidence rates for several cancer types.
Despite the upward trajectory among individuals under 50, researchers emphasize that age remains the primary risk factor for cancer and the disease continues to be relatively uncommon in younger populations. Studies show that between 2001 and 2023, the rate of colorectal cancer diagnoses among people under 50 in England doubled, passing from approximately one case a cada 26 mil pessoas para um a cada 12 mil. A broader 2025 comparison of 42 countries covering the years 2003 through 2017 also identified increased diagnoses of thyroid, breast, colorectal, kidney, uterine cancers, and leukemia among adults aged 20 to 49.
Dietary Habits and Lifestyle Shifts Drive Investigation
Investigators point to a combination of behavioral shifts and lifestyle factors to help explain the rising trend. Marc Gunter, professor of cancer epidemiology at Imperial College London, noted that changing dietary patterns—such as higher consumption of ultra-processed foods, fast food, and sugary beverages alongside increasing rates of sedentary behavior—contribute significantly to overweight and obesity. The World Health Organization (WHO) reports that obesity rates have doubled among adults and quadrupled among adolescents since the 1990s, with one in eight people globally living with the condition. Furthermore, the WCRF notes that roughly 40% of all cancer cases link directly to preventable habits like tobacco use, alcohol consumption, and excessive sun exposure.
Beyond biological and lifestyle factors, researchers are examining whether earlier detection practices account for a portion of the rising numbers. Studies of pancreatic cancer among individuals aged 15 to 39 in the United States identified increases primarily within early-stage diagnoses while mortality rates remained stable, pointing to expanded medical awareness and screening access as driving forces for those specific numbers. At the same time, because younger people typically associate cancer with older demographics, patients under 50 frequently fail to recognize initial warning signs and experience delays in seeking medical evaluation.
Colorectal Cancer Screening Expands in Brazil and Globally
To combat rising numbers and improve survival outcomes, public health authorities are widening access to early detection tools. In Brazil, the Ministry of Health incorporated the fecal immunochemical test (FIT) into the Unified Health System (SUS) to screen asymptomatic men and women aged 50 to 75, a move aimed at expanding prevention for more than 40 million Brazilians. Alexandre Nishimura, a coloproctologist and robotic surgeon, emphasizes that identifying the disease prior to symptom onset remains vital. The earlier we make the diagnosis, the greater the chances of treatment and, above all, of a cure.
Nishimura states.
Medical specialists distinguish persistent warning signs from temporary gastrointestinal issues. Carmen Fong, medical director at Bummed, cautioned that symptoms such as persistent bright red blood in the stool, unexplained weight loss, and changes in bowel habits should not be automatically dismissed as irritable bowel syndrome (IBS). While IBS typically presents with stable patterns of constipation or diarrhea, colorectal cancer symptoms tend to be persistent or progressive. Standard screening methods like colonoscopies allow physicians to detect and remove precancerous polyps before malignant transformation occurs.
Frequently Asked Questions About Early-Onset Cancer
What specific types of cancer are increasing in people under 50?
According to the World Cancer Research Fund analysis, colorectal, kidney, and liver cancers showed increases across the US, England, and the Netherlands.
How does the fecal immunochemical test (FIT) work for bowel cancer screening?
The FIT is a non-invasive stool test used in Brazil’s public health system to detect human hemoglobin, signaling potential bleeding in the lower gastrointestinal tract. The test helps identify asymptomatic adults aged 50 to 75 who require further diagnostic investigation like a colonoscopy.
Why are younger adults experiencing higher rates of certain cancers?
Researchers attribute the shift to a combination of behavioral factors, including rising rates of physical inactivity, obesity, consumption of fast food and ultra-processed items, and alcohol use. WCRF researchers also note that because younger adults do not expect cancer at a young age, they often delay seeking medical care for early warning signs.
Related reading